pI: 4.969 |
Length (AA): 2004 |
MW (Da): 217599 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 8 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 247 | 3qe9 (Y) | 2 | 240 | 20.00 | 0.000000000006 | 0.77 | 0.296355 | 0.48 |
7 | 111 | 2izo (A) | 1 | 159 | 31.00 | 0.000025 | 0.97 | 0.308995 | 0.85 |
1090 | 1426 | 4hm9 (A) | 75 | 425 | 10.00 | 0 | 0.02 | 0.200164 | -0.07 |
1109 | 1337 | 5cwm (A) | 8 | 220 | 15.00 | 0 | 0.1 | 0.239271 | -0.75 |
1339 | 1647 | 3ory (A) | 53 | 333 | 26.00 | 0 | 1 | 0.162192 | 1.17 |
1409 | 1642 | 4q0w (B) | 88 | 984 | 36.00 | 0 | 1 | 0.467766 | 0.29 |
1428 | 1550 | 5t9j (A) | 116 | 241 | 39.00 | 0 | 0.97 | 0.348477 | 1.64 |
1753 | 2001 | 4x0j (A) | 42 | 283 | 13.00 | 0 | 0.08 | 0.253251 | -0.55 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | ME49 Oocyst. | Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Tachyzoite. | Gregory |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | VEG Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 merozoite. | Hehl AB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_128675)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G28030 | DNA repair protein UVH3 |
Babesia bovis | BBOV_II000500 | Rad2 endonuclease, putative |
Brugia malayi | Bm1_05790 | XPG N-terminal domain containing protein |
Candida albicans | CaO19.1324 | similar to RAD13, excision repair protein |
Candida albicans | CaO19.8904 | similar to RAD13, excision repair protein |
Caenorhabditis elegans | CELE_F57B10.6 | Protein XPG-1 |
Cryptosporidium hominis | Chro.40058 | RAD2 |
Cryptosporidium parvum | cgd4_440 | XPG, DNA excision repair protein, flap endonuclease |
Dictyostelium discoideum | DDB_G0294290 | xeroderma pigmentosum group G family protein |
Drosophila melanogaster | Dmel_CG10890 | mutagen-sensitive 201 |
Echinococcus granulosus | EgrG_000321400 | DNA repair protein complementing XP G cells |
Entamoeba histolytica | EHI_100400 | DNA-repair protein, putative |
Echinococcus multilocularis | EmuJ_000321400 | DNA repair protein complementing XP G cells |
Homo sapiens | ENSG00000270181 | BIVM-ERCC5 readthrough |
Homo sapiens | ENSG00000134899 | excision repair cross-complementation group 5 |
Loa Loa (eye worm) | LOAG_00986 | hypothetical protein |
Mus musculus | ENSMUSG00000026048 | excision repair cross-complementing rodent repair deficiency, complementation group 5 |
Neospora caninum | NCLIV_037790 | RAD2 endonuclease, putative |
Oryza sativa | 4331991 | Os03g0205400 |
Plasmodium berghei | PBANKA_0303700 | DNA repair protein RAD2, putative |
Plasmodium falciparum | PF3D7_0206000 | DNA repair protein RAD2, putative |
Plasmodium knowlesi | PKNH_0414900 | DNA repair protein RAD2, putative |
Plasmodium vivax | PVX_003735 | DNA repair protein RAD2, putative |
Plasmodium yoelii | PY01122 | XPG I-region, putative |
Saccharomyces cerevisiae | YGR258C | Rad2p |
Schistosoma japonicum | Sjp_0023590 | DNA-repair protein rad13, putative |
Schistosoma mansoni | Smp_123940 | xp-G/rad2 DNA repair endonuclease family |
Schmidtea mediterranea | mk4.006295.00 | |
Schmidtea mediterranea | mk4.005914.00 | |
Toxoplasma gondii | TGME49_268560 | XPG N-terminal domain-containing protein |
Theileria parva | TP04_0530 | DNA repair protein rad2, putative |
Theileria parva | TP04_0531 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_046610 | flap endonuclease-1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_F57B10.6 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_0303700 | Plasmodium berghei | Dispensable | plasmo |
TGME49_268560 this record | Toxoplasma gondii | Essentiality uncertain | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.7
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | excision repair cross-complementation group 5 | Compounds | References |